Detalhe da pesquisa
1.
Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion.
Tumour Biol
; 36(6): 4309-17, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25613068
2.
Clinical outcomes of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and anti-PD-1 immunotherapy for unresectable intrahepatic cholangiocarcinoma.
J Dig Dis
; 23(8-9): 535-545, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36148493
3.
Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1.
Aging (Albany NY)
; 13(16): 20094-20115, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032605
4.
Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma.
Bioengineered
; 12(1): 1202-1211, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830865
5.
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.
Cancer Cell
; 30(3): 444-458, 2016 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569582
6.
Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
Oncotarget
; 6(37): 40223-34, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474280
7.
MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.
Int J Oncol
; 45(2): 629-40, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859810